Although the concept of bringing technology solutions from engineering, physics or data sciences to life sciences isn't new, TechBio has certainly recently emerged as a sector in its own rights. Even if the label is bringing opportunities by dragging more attention to those enabling technologies providers, it doesn't address all the challenges inherent to the multidisciplinary nature of these companies. The first big challenge being the early stage fundraising.
This session will gather investors from different side of the TechBio spectrum and entrepreneurs who successfully raised money in TechBio to share their views and advices on how to approach fundraising in TechBio.
It is free to attend and open to any TechBio entrepreneur or innovator.
Programme:
10.30 - Welcome coffee and tea
11.00 - Introduction to TechBio investment landscape
Aline Charpentier, Bruntwood SciTech
11.10 - TechBio - what do the investors want?
Jo Slota-Newton, IQ Capital
Pierre Socha, Amadeus Capital Partners
Oliver Sims, Octopus Ventures
12.00 - Accelerating success in TechBio - with the contribution of accelerate@babraham, StartCodon, Illumina Accelerator, O2h
12.30 - lunch
13.00 - Building a wining TechBio narrative
Claire Thompson, Agility Life Sciences
13.10 - Sharing success - what makes a good TechBio business proposition?
Jason Foster, OriBiotech
Jenny Barnett, Monument Therapeutics
Steve Harvey, Camena Bioscience
14.00 - Networking
